These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17940502)

  • 41. Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa.
    Kodani I; Shomori K; Osaki M; Kuratate I; Ryoke K; Ito H
    Pathobiology; 2001; 69(3):150-8. PubMed ID: 11872961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.
    Masciullo V; Ferrandina G; Pucci B; Fanfani F; Lovergine S; Palazzo J; Zannoni G; Mancuso S; Scambia G; Giordano A
    Clin Cancer Res; 2000 Dec; 6(12):4816-22. PubMed ID: 11156240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53 and related proteins in epithelial ovarian cancer.
    Sengupta PS; McGown AT; Bajaj V; Blackhall F; Swindell R; Bromley M; Shanks JH; Ward T; Buckley CH; Reynolds K; Slade RJ; Jayson GC
    Eur J Cancer; 2000 Dec; 36(18):2317-28. PubMed ID: 11094305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancer.
    Pinto AE; André S; Laranjeira C; Soares J
    Pathology; 2005 Feb; 37(1):45-50. PubMed ID: 15875733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
    Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
    J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer.
    Liu M; Li JS; Tian DP; Huang B; Rosqvist S; Su M
    Histol Histopathol; 2013 Apr; 28(4):481-92. PubMed ID: 23329420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
    Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
    Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
    Li T; Xue H; Guo Y; Guo K
    Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High expression of CDC6 is associated with accelerated cell proliferation and poor prognosis of epithelial ovarian cancer.
    Deng Y; Jiang L; Wang Y; Xi Q; Zhong J; Liu J; Yang S; Liu R; Wang J; Huang M; Tang C; Su M
    Pathol Res Pract; 2016 Apr; 212(4):239-46. PubMed ID: 26920249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma.
    García-Velasco A; Mendiola C; Sánchez-Muñoz A; Ballestín C; Colomer R; Cortés-Funes H
    Clin Transl Oncol; 2008 Jun; 10(6):367-71. PubMed ID: 18558584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma.
    Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X
    Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of INPP4B protein immunohistochemistry in ovarian cancer.
    Salmena L; Shaw P; Fans I; McLaughlin ; Rosen B; Risch H; Mitchell C; Sun P; Narod SA; Kotsopoulos J
    Eur J Gynaecol Oncol; 2015; 36(3):260-7. PubMed ID: 26189250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical significance of astrocyte elevated gene-1 expression in human epithelial ovarian carcinoma.
    Meng F; Luo C; Ma L; Hu Y; Lou G
    Int J Gynecol Pathol; 2011 Mar; 30(2):145-50. PubMed ID: 21293286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sox10 expression in ovarian epithelial tumors is associated with poor overall survival.
    Kwon AY; Heo I; Lee HJ; Kim G; Kang H; Heo JH; Kim TH; An HJ
    Virchows Arch; 2016 May; 468(5):597-605. PubMed ID: 26951260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer.
    Skírnisdóttir I; Seidal T
    Int J Gynecol Cancer; 2011 Aug; 21(6):1024-31. PubMed ID: 21792012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens.
    Plisiecka-Hałasa J; Karpińska G; Szymańska T; Ziółkowska I; Madry R; Timorek A; Debniak J; Ułańska M; Jedryka M; Chudecka-Głaz A; Klimek M; Rembiszewska A; Kraszewska E; Dybowski B; Markowska J; Emerich J; Płuzańska A; Goluda M; Rzepka-Górska I; Urbański K; Zieliński J; Stelmachów J; Chrabowska M; Kupryjańczyk J
    Ann Oncol; 2003 Jul; 14(7):1078-85. PubMed ID: 12853350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Markers of cell division cycle in glioblastoma: significance in prediction of treatment response and patient prognosis.
    Yousaf J; Hills C; Dixit S; Achawal S; O'Brien D; Greenman J; Scott IS
    Br J Neurosurg; 2013 Dec; 27(6):752-8. PubMed ID: 23477614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival.
    Ma R; Tang Z; Sun K; Ye X; Cheng H; Chang X; Cui H
    Pathol Res Pract; 2018 Aug; 214(8):1115-1122. PubMed ID: 29921495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.